Services
[ Global Product Development Services ] [ Trials Management Services ] [ Dedicated Clinical Operations Centers ] [ Local Country Clinical Trial Environments ] [ Early Development Services ] [ Late Phase Services ] [ Drug Safety Management ] [ Electronic Regulatory Submissions ]
Global Product Development Services
[ Focus ] [ Therapeutic Specialization ] [ Services ] [ Meet the Experts ]
Click the play button to review a brief overview of PRA's Global Product Development Services:
Global Product Development Services (GPDS) is a specialized group within
PRA that provides expert consultation and management services taking
products from the late preclinical phase (transition from bench to bedside)
all the way to the marketing stage, primarily in the United States, Canada
and Europe.
Our overall goal is to provide both external and internal customers with
opinion-leader level therapeutic expertise and therapeutic area-specific
leadership in the design and implementation of high quality product
development programs, and help reach key development milestones in a
cost-effective manner.
Page last updated:
02 July 2008
|
